General Reporting Rules	2018-E
UNITED STATES	OMB APPROVAL
SECURITIES AND EXCHANGE COMMISSION	OMB Number:        3235-0058
Washington, D.C. 20549	Estimated average burden
	Hours per response..........2.50
	SEC FILE NUMBER
	0-53600.
	CUSIP NUMBER
	169454C 10 7

FORM 12b-25

NOTIFICATION OF LATE FILING

(Check One):   ¨ Form 10-K   ¨ Form 20-F   ¨ Form 11-K   x  Form 10-Q   ¨ Form N-SAR

For Period Ended: December 31, 2013_

¨Transition Report on Form 10-K 

¨ Transition Report on Form 20-F

¨ Transition Report on Form 11-K

¨ Transition Report on Form 10-Q

¨ Transition Report on Form N-SAR

For the Transition Period Ended:

Read Instruction (on back page) Before Preparing Form. Please Print or Type.

Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.

If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:

PART I--REGISTRANT INFORMATION

China YCT International Group, Inc.

Full Name of Registrant

_____________________________

Former Name if Applicable

 c/o Shandong Spring Pharmaceutical Co., Ltd Economic Development Zone

Address of Principal Executive Office (Street and Number)

Gucheng Road Sishui County Shandong Province PR China, 373200 

City, State and Zip Code

PART II-- RULES 12b-25(b) AND (c)

If the subject report could not be filed without reasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)

¨ (a) The reasons described in reasonable detail on Part III of this form could not be eliminated without unreasonable effort or expense;

x (b) The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, 11-K, Form N-SAR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report of transition report on Form 10-Q, or portion thereof will be filed on or before the fifth calendar day following the prescribed due date; and

¨ (c) The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

PART III- NARRATIVE

State below in reasonable detail why the Form 10-K, 10-Q, N-SAR, or the transition report or portion thereof, could not be filed within the prescribed time period, (Attach Extra Sheets if Needed)

The Registrant will be delayed in filing its 10-Q because the interim review of the Registrant's financial statements for the three and nine months ending December 31, 2013 has not been completed.

PART IV-- OTHER INFORMATION

(1) Name and telephone number of person in regard to this notification

Steven W. Schuster, Esq.	(212)	448-1100
(Name)	(Area Code)	(Telephone Number)

(2) Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months (or for such shorter) period that the registrant was required to file such reports) been filed? If answer no, identify report(s). x Yes ¨ No

(3) Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof? x Yes ¨ No

If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

See Exhibit A

CHINA YCT INTERNATIONAL GROUP, INC.

(Name of Registrant as Specified in Charter)

has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

Date     February 14, 2014	By    Yan Tinghe
	Yan Tinghe, Chief Executive Officer

INSTRUCTION: The form may be signed by an executive officer of the registrant or by any other duly authorized representative. The name and title of the person signing the form shall be typed or printed beneath the signature. If the statement is signed on behalf of the registrant by an authorized representative (other than an executive officer), evidence of the representative’s authority to sign on behalf of the registrant shall be filed with the form.

ATTENTION 

Intentional misstatements or omissions of fact constitute Federal Criminal Violations (See 18 U.S.C. 1001).

GENERAL INSTRUCTION

1. This form is required by Rule 12b-25 (17 CFR 240.12b-25) of the General Rules and Regulations under the Securities Exchange Act of 1934.

2. One signed original and four conformed copies of this form and amendments thereto must be completed and filed with the Securities and Exchange Commission, Washington, D.C. 20549, in accordance with Rule 0-3 of the General Rules and Regulations under the Act. The information contained in or filed with the form will be made a matter of public record in the Commission files.

3. A manually signed copy of the form and amendments thereto shall be filed with each national securities exchanged on which any class of securities of the registrant is registered.

4. Amendments to the notifications must also be filed on form 12b-25 but need not restate information that has been correctly furnished. The form shall be clearly identified as an amended notification.

5. Electronic Filers. This form shall not be used by electronic filers unable to timely file a report solely due to electronic difficulties. Filers unable to submit a report within the time period prescribed due to difficulties in electronic filing should comply with either Rule 201 or Rule 202 of Regulation S-T or apply for an adjustment in filing date pursuant to Rule 13-(b) of Regulation S-T.

EXHIBIT A

During the three months ended December 31, 2013, the Registrant realized $8,276,400 in revenue and $2,196,757 in net income, as compared to $6,922,363 in revenue and $4,648,852 in net income during the three months ended December 31, 2012 . During the nine months ended December 31 2013, the Registrant realized $24,633,947 in revenue and $6,558,255 in net income, as compared to $23,521,007 in revenue and $13,071,667 in net income during the nine months ended December 31, 2012. The decrease in net income was mainly due to the Company’s unrealized gain on a derivative of $ 3,872,370 for the three months ended December 31, 2012 that resulted from the adjustment on derivative liability arising from the termination of a purchase agreement for a patent, but there was no unrealized gain on derivative for the three months ended December 31, 2013.